{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:04:48Z","timestamp":1758819888320},"reference-count":59,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3205,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01181.x","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T06:04:39Z","timestamp":1164175479000},"page":"1-7","source":"Crossref","is-referenced-by-count":5,"special_numbering":"supplement s151","title":["Botulinum toxin injection therapy in the management of lower urinary tract dysfunction"],"prefix":"10.1155","volume":"60","author":[{"given":"A. K.","family":"PATEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"CHAPPLE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncpuro0034","article-title":"Botulinum toxin in urology: evaluation using an evidence-based approach","volume":"1","author":"Smith","year":"2004","journal-title":"Nat Clin Pract Urol"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1742-1241.2006.01184.x","article-title":"Treatment-resistant detrusor overactivity-underlying pharmacology and potential mechanism","volume":"60","author":"Andersson","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1742-1241.2006.01183.x","article-title":"Detrusor-sphincter dyssynergia","volume":"60","author":"Castro-Diaz","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1742-1241.2006.01182.x","article-title":"Refractory neurogenic detrusor overactivity","volume":"60","author":"Cruz","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2006.01212.x","article-title":"The emerging role of intravesicle botulinum toxin therapy in idiopathic detrusor overactivity","volume":"60","author":"Patel","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1742-1241.2006.01180.x","article-title":"Botulinum-A toxin: an exciting new treatment option for prostatic disease","volume":"60","author":"Thomas","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 151","key":"10.1111\/j.1742-1241.2006.01181.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1742-1241.2006.01185.x","article-title":"Sensory bladder disorders","volume":"60","author":"Nordling","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","article-title":"Botulinum toxin as a new therapy option for voiding disorders: current state of the art","volume":"44","author":"Leippold","year":"2003","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2003.04714.x","article-title":"Botulinum toxin and its applications in the lower urinary tract","volume":"93","author":"Harper","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/0929867053363315","article-title":"Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin","volume":"12","author":"Maria","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1046\/j.1526-4610.43.7s.1.x","article-title":"Botulinum toxin type A: myths, facts, and current research","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB14|cit14","article-title":"What is the best dose for intravesical botulinum-A toxin injection in overactive bladder treatment? A prospective randomised preliminary study","author":"Truzzi","year":"2004","journal-title":"Joint meeting of the International Continence Society (ICS) and the International Uro-Gynaecological Association (IUGA)"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB15|cit15","first-page":"254","article-title":"Dose-finding prospective randomized study to evaluate the efficacy and safety of botulinum-A toxin for refractory idiopathic overactive bladder","author":"Gousse","year":"2005","journal-title":"Int Continence Soc Ann Meet"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1569-9056(02)80519-X","article-title":"Botulinum toxin type A intravesical injections for intractable bladder overactivity","volume":"1","author":"Radziszewski","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB17|cit17","article-title":"English botulinum toxin-A in the treatment of neurogenic detrusor overactivity","author":"Del Popolo","year":"2003","journal-title":"Int Continence Soc Ann Meet"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB18|cit18","first-page":"521","article-title":"Botulinum toxin-A to treat detrusor hyperreflexia in spinal cord injured patients","volume":"20","author":"Schurch","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB20|cit20","article-title":"Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI) - a prospective randomized study to compare 30 vs. 10 injection sites","volume":"93","author":"Karsenty","year":"2005","journal-title":"Int Continence Soc Ann Meet"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB23|cit23","first-page":"412","article-title":"Trigonum and bladder base injection of botulinum toxin A (BoNT) in patients with severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation","volume":"20","author":"Zermann","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1310\/1640-XEPP-Y33E-TMK8","article-title":"Botulinum-A toxin injections as a treatment for refractory detrusor hyperreflexia","volume":"8","author":"Kennelly","year":"2003","journal-title":"Top Spinal Cond Inj Rehabil"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB25|cit25","article-title":"The effect of repeated injections of botulinum toxin type A on the efficacy of the treatment of neurogenic overactive bladder and the urinary bladder","volume":"242","author":"Karsenty","year":"2005","journal-title":"Int Continence Soc Ann Meet"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11934-004-0088-5","article-title":"Urologic applications of botulinum toxin therapy for voiding dysfunction","volume":"5","author":"Rackley","year":"2004","journal-title":"Curr Urol Rep"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"issue":"6 Pt 1","key":"10.1111\/j.1742-1241.2006.01181.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB29|cit29","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1464-410X.1992.tb15793.x","article-title":"Botulinum toxin in the treatment of chronic urinary retention in women","volume":"70","author":"Fowler","year":"1992","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB32|cit32","first-page":"522","article-title":"Botulinum-A toxin in the treatment of detrusor hyperreflexia","volume":"20","author":"Del Popolo","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB35|cit35","first-page":"76","article-title":"ATP release from normal human urinary bladder and porcine bladder","volume":"3","author":"Kumar","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.ju.0000108120.28291.eb","article-title":"Electrical characteristics of suburothelial cells isolated from the human bladder","volume":"171","author":"Sui","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB37|cit37","first-page":"76","article-title":"Distribution of purinergic receptors in urinary bladder of porcine and normal human urinary bladder","volume":"3","author":"Kumar","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)01544-3","article-title":"Bladder afferents and their role in the overactive bladder","volume":"59","author":"Fowler","year":"2002","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB39|cit39","first-page":"76","article-title":"Purinergic activity in sensory disorders of the bladder","volume":"3","author":"Kumar","year":"2004","journal-title":"Eur Urol Suppl"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.urology.2004.10.057","article-title":"Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model","volume":"65","author":"Atiemo","year":"2005","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin a has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00042307-200411000-00006","article-title":"Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update","volume":"14","author":"Cruz","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(03)00114-X","article-title":"Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions","volume":"61","author":"Smith","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuint.2005.04.021","article-title":"Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A","volume":"47","author":"Smith","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/nau.20090","article-title":"Botulinum toxin for the treatment of lower urinary tract symptoms: a review","volume":"24","author":"Sahai","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB50|cit50","article-title":"Botulinum A toxin intravesical injections reduce nerve growth factor bladder tissue content in patients affected by neurogenic detrusor overactivity","author":"Giannantoni","year":"2005","journal-title":"Int Continence Soc Ann Meet"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","article-title":"Botox induced prostatic involution","volume":"37","author":"Doggweiler","year":"1998","journal-title":"Prostate"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clindermatol.2003.11.006","article-title":"Pharmacology and immunology of botulinum toxin type A. serotypes","volume":"21","author":"Aoki","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-0528.2004.00315.x","article-title":"The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator and muscles","volume":"112","author":"Thomson","year":"2005","journal-title":"BJOG"},{"key":"10.1111\/j.1742-1241.2006.01181.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","article-title":"Botulinum toxin-new mechanisms, new therapeutic directions","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01181.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:05:02Z","timestamp":1643331902000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01181.x"}},"subtitle":["BOTULINUM TOXIN INJECTION THERAPY"],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01181.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,22]]}}}